Issue |
Title |
File |
No 3 (2023) |
FMR1 inherited from women with premature ovarian failure: case series |
|
Rshtuni S.D., Zaretskaya N.V., Kuznetsova M.V., Marchenko L.A.
|
No 2 (2025) |
A clinical case of mosaic variant of the Shereshevsky–Turner syndrome in combination with hyperandrogenism |
|
Fetisova I.N., Smirnova A.V., Malyshkina A.I., Fetisov N.S.
|
No 2 (2025) |
A model for diagnosing fetal growth restriction using functional diagnostic methods |
|
Volochaeva M.V., Timofeeva A.V., Fedorov I.S., Kan N.E., Tyutyunnik V.L., Ryzhova K.O., Gasymova S.R.
|
No 9 (2024) |
A new perspective on the causes of reproductive failure in women with chronic endometritis |
|
Zefirova T.P., Sadykova D.A., Dzamukov R.A., Tolibova G.K., Gusev V.I., Evsegneeva I.V.
|
No 1 (2023) |
A possibility for health improvement in overweight and obese women at the stage of pregravid preparation |
|
Radzinsky V.E., Solovyeva A.V., Kuleshov V.M., Katkova N.Y., Mingaleva N.V., Korotkikh I.N., Oboskalova T.A., Vorontsova A.V.
|
No 11 (2024) |
A profile of autoantibodies to steroid hormones and steroidogenic enzymes in women with endometriosis |
|
Menzhinskaya I.V., Pavlovich S.V., Melkumyan A.G., Chuprynin V.D.
|
No 1 (2024) |
A rare case of ovarian inclusion cyst combined with cholesterosis and ossification |
|
Fedotova E.P., Shalonya T.A., Sergienko O.I., Nasyrov R.A.
|
No 11 (2024) |
A rare localization of ectopic pregnancy: cervical and cesarean scar pregnancy |
|
Danilov A.A., Kozachenko A.V.
|
No 6 (2023) |
A successful outcome of in vitro fertilization in absolute teratozoospermia after spermatozoon selection by the zeta potential |
|
Gamidova P.S., Makarova N.P., Smolnikova V.Y., Lobanova N.N.
|
No 2 (2024) |
Abnormalities of the fetal heart rhythm: fetal bradyarrhythmias |
|
Yannaeva N.E., Bokeriya E.L.
|
No 11 (2023) |
Abnormalities of the fetal heart rhythm: irregular rhythm and the most common fetal tachyarrhythmias |
|
Yannaeva N.E., Bokeriya E.L.
|
No 3 (2023) |
Activated glycyrrhizic acid in the combination treatment of patients with vaginitis and dysbiosis: results of a multicenter study |
|
Kachalina O.V., Matuzkova A.A.
|
No 6 (2024) |
Activation of ovarian function in patients with diminished ovarian reserve through administration of extracellular vesicles |
|
Martirosyan Y.O., Nazarenko T.A., Kadaeva A.I., Goryunov K.V., Shevtsova Y.A.
|
No 7 (2024) |
Acute appendicitis, appendectomy and female fertility: an assessment of the problem |
|
Milyukov V.Y., Bartosh N.O., Brileva E.A., Zakirova D.R.
|
No 2 (2023) |
Acute twin-to-twin transfusion in monochorionic multiple pregnancy |
|
Mikhailov A.V., Romanovsky A.N., Volchenkova V.E., Kuznetsov A.A., Kyanksep A.N., Saveleva A.A., Osipova A.V., Tcyganova M.K.
|
No 3 (2025) |
Additional benefits of menopausal hormone therapy with drospirenone for healthy longevity |
|
Andreeva E.N., Yureneva S.V., Yarmolinskaya M.I.
|
No 3 (2024) |
Algorithm for diagnosis and treatment of gastroesophageal reflux disease in pregnant women |
|
Tyutyunnik V.L., Kan N.E., Mikhailova O.I., Mirzabekova D.D.
|
No 11 (2024) |
Algorithm for providing medical care to patients with placenta percreta |
|
Prikhodko A.M., Amiraslanov E.Y., Chuprynin V.D., Kan N.E., Baev O.R.
|
No 9 (2023) |
All that practitioners should know about ductus venosus |
|
Yarygina T.A., Gasanova R.M., Marzoeva O.V., Sypchenko E.V., Gus A.I.
|
No 2 (2024) |
Amino acid profile of blood plasma and follicular fluid in women with infertility and diminished ovarian reserve |
|
Shevtsova M.A., Gavisova A.A., Krasnova N.A., Aksenenko A.A., Novoselova A.V., Khazzhar F., Chagovets V.V., Frankevich V.E.
|
No 3 (2024) |
Analogues of gonadotropin-releasing hormone in the treatment of women with uterine fibroids |
|
Dovletkhanova E.R., Abakarova P.R., Mezhevitinova E.A.
|
No 3 (2023) |
Analysis of HLA class I gene (G) polymorphic alleles in pregnant women in the North-West Region of the Russian Federation |
|
Shengelia M.O., Bespalova O.N., Ivashchenko T.E., Frank N.I., Sultanov I.Y., Nasykhova Y.A., Glotov A.S.
|
No 6 (2024) |
Analysis of pathomorphological characteristics of the placental structure in cases of prenatally diagnosed fetal congenital heart disease |
|
Yarygina T.A., Gasanova R.M., Marzoeva O.V., Sypchenko E.V., Leonova E.I., Lyapin V.M., Shchegolev A.I., Gus A.I.
|
No 7 (2024) |
Analysis of perinatal and infant outcomes in children born to mothers who were administered cellular technologies during cesarean section |
|
Pekareva N.A., Baranov I.I., Silachev D.N., Pekareva E.O., Pozdnyakov I.M., Pekarev O.G.
|
No 5 (2024) |
Analysis of the structure of gynecological diseases and extent of surgery in patients of different age groups supervised in the cervical and endometrial pathology office |
|
Rosyuk E.A., Oboskalova T.A., Verba T.E., Salimova I.V., Tureeva A.V.
|
No 8 (2024) |
Analytical review of the national and international clinical guidelines for the management of pregnancies complicated by fetal growth restriction |
|
Khodzhaeva Z.S., Stolyarova E.V., Kholin A.M., Gus A.I.
|
No 8 (2024) |
Anatomical pathology of the umbical cord in cases of fetal congenital heart disease |
|
Yarygina T.A., Gasanova R.M., Marzoeva O.V., Sypchenko E.V., Leonova E.I., Lyapin V.M., Shchegolev A.I., Gus A.I.
|
No 8 (2023) |
Androgen priming in a poor ovarian stimulation response |
|
Pshenisnova I.V., Yakovlev P.P.
|
No 1 (2024) |
Antenatal colostrum expression: a modern view on the issue |
|
Olina A.A., Yakubovskaia E.A.
|
No 12 (2024) |
Antibacterial therapy in pelvic inflammatory diseases: current trends |
|
Dovletkhanova E.R., Abakarova P.R.
|
No 2 (2023) |
Antibodies to angiotensin-converting enzyme 2 in infertile patients with a history of COVID-19 and in fertile women |
|
Menzhinskaya I.V., Ermakova D.M., Syrkasheva A.G., Drapkina Y.S., Dolgushina N.V.
|
No 1 (2024) |
Application of Alive Collagen supplement in genitourinary menopausal syndrome |
|
Bakhtiyarov K.R., Kuzmina P.I., Cherkashina A.V.
|
No 7 (2023) |
Application of CO2-fraction laser photothermolysis in gynecological practice |
|
Gorbunova E.A., Apolikhina I.A., Ramazanova M.O.
|
No 12 (2023) |
Application of fluorescent in situ hybridization in the diagnosis of bacterial vaginosis |
|
Savicheva A.M., Krysanova A.A., Shalepo K.V., Spasibova E.V., Budilovskaya O.V., Khusnutdinova T.A., Tapilskaya N.I., Kogan I.Y., Swidsinski A.V., Swidsinski S.
|
No 2 (2024) |
Application of noninvasive prenatal screening for aneuploidies in multiple pregnancies |
|
Barkov I.Y., Bolshakova A.S., Tetruashvili N.K., Shubina J., Goltsov A.Y., Trofimov D.Y.
|
No 3 (2024) |
Application of various machine learning techniques to the analysis of clinical, anamnestic, and embryological data of patients undergoing assisted reproductive technologies |
|
Drapkina Y.S., Makarova N.P., Vasiliev R.A., Amelin V.V., Frankevich V.E., Kalinina E.A.
|
No 10 (2024) |
Asherman’s syndrome in patients of reproductive age |
|
Sulima A.N., Rumyantseva Z.S., Nikolaeva E.I., Efremova N.V., Bakharovskaya A.S.
|
No 2 (2023) |
Assessment of quality of life, psycho-emotional state, eating behavior, obstetric and perinatal outcomes in pregnant women with early and late gestational diabetes mellitus |
|
Batrak N.V., Malyshkina A.I., Tkachenko A.S.
|
No 7 (2024) |
Assessment of the impact of male factor infertility on the outcomes of assisted reproductive technology programs using machine learning techniques |
|
Drapkina Y.S., Makarova N.P., Kulakova E.V., Kalinina E.A.
|
No 7 (2024) |
Assessment of the potential use of antioxidant support in infertility of various etiologies |
|
Berezina D.A., Karimova A.A.
|
No 8 (2023) |
Assessment of the state of the fetus by dopplerometry in pregnant women with placenta increta |
|
Omarova H.M., Omarova R.H., Khashaeva T.H., Magomedova I.K.
|
No 10 (2024) |
Association between interleukin-6 and thrombomodulin levels and pathomorphological changes in early reproductive losses |
|
Taizhanova D.Z., Zubkov D.V., Kamyshansky E.K., Komlichenko E.V., Magalov I.S., Sorokina M.A.
|
No 2 (2023) |
Association between new coronavirus infection and fetal growth restriction |
|
Lipatov I.S., Tezikov Y.V., Kalinkina O.B., Tyutyunnik V.L., Kan N.E., Majorova M.O., Yakovleva M.A.
|
No 10 (2024) |
Association between xenobiotic detoxification system gene polymorphisms and hormone replacement therapy efficacy in women with premature ovarian insufficiency |
|
Averkova V.G., Yureneva S.V., Donnikov A.E.
|
No 5 (2024) |
Association of COL1A1, ESR1, and VDR gene polymorphisms with the risk of pelvic floor dysfunction in postpartum women |
|
Mikhelson A.A., Lukianova K.D., Lazukina M.V., Varlamova A.L., Tretyakova T.B., Varaksin A.N., Konstantinova E.D., Maslakova T.A.
|
No 3 (2024) |
Association of polymorphic variants RS699517 and RS2790 of the maternal TYMS gene with newborn birthweight |
|
Reshetnikova Y.N., Ponomarenko I.V., Churnosov M.I., Reshetnikov E.A.
|
No 8 (2024) |
Association of polymorphism of genes in the xenobiotic biotransformation system with early first pregnancy loss in a large industrial region |
|
Shramko S.V., Matoshin S.V., Gulyaeva O.N., Samus I.V.
|
No 7 (2023) |
Association of red blood cell distribution width and high sensitivity c-reactive protein with polycystic ovarian syndrome |
|
Al-Ghazali B.S., Salman M.F., Fahad A.M.
|
No 3 (2024) |
Balance of pro-inflammatory and anti-inflammatory cytokines of fetal membranes of patients with prelabor rupture of membranes at term |
|
Kaganova M.A., Spiridonova N.V.
|
No 6 (2024) |
Balance of serum cytokines regulating inflammatory activity in patients with leiomyoma |
|
Konenkov V.I., Shevchenko A.V., Koroleva E.G., Prokofiev V.F., Timofeeva Y.S., Aidagulova S.V., Marinkin I.O.
|
No 3 (2025) |
Biological and biochemical protective factors of the vagina and cervical canal: mechanisms of stability and correction options |
|
Kira E.F., Priputnevich T.V., Kira E.E.
|
No 8 (2024) |
Biological and chronological aging. Ways to slow down aging |
|
Khadzhieva N.K., Alieva A.M., Nikitin I.G.
|
No 1 (2024) |
Birth of a child conceived using assisted reproductive technology in a woman with recurrent miscarriage and combined form of thrombophilia |
|
Kraevaya E.E., Kirsanova T.V., Shmakov R.G.
|
No 10 (2023) |
BRCA-associated breast cancer during pregnancy |
|
Bakhova L.A., Shevlyukova T.P., Keln A.A., Shvedsky M.S., Mateykovich E.A., Nekrasova O.V., Shkuratova V.V., Karmaeva O.S.
|
No 7 (2024) |
Breastfeeding after cesarean section: difficulties in the first four months |
|
Ladodo O.B., Karavaeva A.L., Timofeeva L.A., Zubkov V.V., Degtyarev D.N., Nikolaeva A.V., Chutkova D.A.
|
No 2 (2023) |
Cardiometabolic risk factors in women undergoing the menopausal transition and the potential of drospirenone-containing contraceptive in the correction of the identified abnormalities |
|
Tolstov S.N., Salov I.A., Rebrov A.P.
|
No 4 (2023) |
Cardiovascular consequences of great obstetrical syndromes |
|
Akhmadeyev N.R., Fatkullin I.F., Fatkullina L.S.
|
No 11 (2024) |
Cardiovascular risk assessment tools for optimizing pregravid preparation: the results of the study on working women of reproductive age |
|
Salov I.A., Malinova L.I., Tolstov S.N., Zhuk A.A., Denisova T.P.
|
No 1 (2023) |
Cell subpopulation composition and cytokine content in peripheral blood before spontaneous and induced labor |
|
Tysyachnyi O.V., Inviyaeva E.V., Vtorushina V.V., Krechetova L.V., Baev O.R.
|
No 3 (2025) |
Cell-free components of malignant ascites and their potential role in effective therapy for serous ovarian cancer |
|
Slonov A.V., Shender V.O., Aleshikova O.I., Gerfanova E.V., Babaeva N.A., Ashrafyan L.A., Sukhikh G.T.
|
No 1 (2025) |
Cellular components of malignant ascites and their potential role in effective therapy for serous ovarian cancer |
|
Slonov A.V., Shender V.O., Aleshikova O.I., Gerfanova E.V., Babaeva N.A., Akopyan E.G., Antonova I.B., Ashrafyan L.A., Sukhikh G.T.
|
No 9 (2024) |
Cesarean scar ectopic pregnancy |
|
Sulima A.N., Bakharovskaya A.S.
|
No 3 (2025) |
Challenges and opportunities for integrating programs for the prevention and treatment of non-communicable diseases with maternal and child health care |
|
Yarotskaya E.L., Ionov O.V., Sharafutdinova D.R., Khamatkhanova E.M., Axelrod S.V.
|
No 6 (2024) |
Changes in the composition of intestinal microbiota and their association with cortisol, melatonin, tumor necrosis factor-α, and interleukin-17 levels in women with idiopathic recurrent miscarriage |
|
Gumenyuk L.N., Gavrilov M.V., Puchkina G.A., Asanova F.S., Medzhitova D.R., Bordyugov M.D., Tishchenko V.A., Rudeva K.A.
|
No 3 (2025) |
Characteristic effect of prednisolone in vitro administered in the form of prednisolone sodium phosphate in a combined preparation on biofilm-forming microorganisms of the vaginal biotope |
|
Khusnutdinova T.A., Spasibova E.V., Shalepo K.V., Budilovskaya O.V., Krysanova A.A., Cheberya A.S., Cheberya A.R., Savicheva A.M.
|
No 3 (2025) |
Characteristics of Buserelin-depo use in the treatment for comorbid pathologies of reproductive organs |
|
Khashukoeva A.Z., Agaeva M.I., Agaeva Z.A., Lobacheva Y.I., Smagina Y.A.
|
No 7 (2024) |
Characteristics of CACNA1C protein expression levels in the round ligaments of the uterus in patients with genital prolapse |
|
Cheremin M.M., Smolnova T.Y., Krasnyi A.M., Sadekova A.A., Chuprynin V.D.
|
No 7 (2024) |
Characteristics of circadian regulation in patients with miscarriage |
|
Baroeva M.D., Datieva F.S., Popova L.S., Tsallagova L.V.
|
No 4 (2024) |
Characteristics of consultations for patients aged over 45 years |
|
Dubrovina S.O.
|
No 11 (2024) |
Characteristics of modern colorectal surgery: a surgical and gynecological perspective |
|
Chuprynin V.D., Shvagireva S.V., Khilkevich E.G., Chursin V.V., Melnikov M.V., Matronitsky R.B.
|
No 8 (2023) |
Chemomicrobiomic analysis of myoinositol, D-chiroinositol, folic acid and pyroglutamate anion in the nutritional support of female reproductive system |
|
Torshin I.Y., Gromov A.N., Gromova O.A.
|
No 2 (2024) |
Chorioamnionitis: diagnosis and role in complications during pregnancy and fetal development |
|
Shchegolev A.I., Tumanova U.N., Serov V.N.
|
No 7 (2024) |
Chromosomal abnormalities in nonimmune hydrops fetalis: diagnosis and management of pregnancy |
|
Lyushnina D.G., Tetruashvili N.K., Shubina J., Rogacheva M.S., Zaretskaya N.V., Bolshakova A.S., Barkov I.Y., Sadelov I.O., Pak V.S., Bokeriya E.L., Trofimov D.Y.
|
No 6 (2024) |
Chronic endometritis |
|
Dubrovina S.O., Bozhinskaya D.M., Gimbut V.S., Bogunova D.Y., Tsirkunova N.S., Tsirkunova K.G.
|
No 7 (2023) |
Chronic nonspecific cervicitis |
|
Firichenko S.V., Popova E.O., Smirnova S.O.
|
No 3 (2025) |
Clinical and anamnestic characteristics of isolated and combined genital endometriosis |
|
Ponomareva T.A., Altukhova O.B., Ponomarenko I.V., Churnosov M.I.
|
No 3 (2025) |
Clinical and anamnestic factors and lifestyle features significantly influencing apical prolapse |
|
Dubinskaya E.D., Gasparov A.S., Matskevich E.N., Babicheva I.A.
|
No 9 (2023) |
Clinical and anamnestic factors in the prediction and diagnosis of fetal growth restriction |
|
Volochaeva M.V., Kan N.E., Tyutyunnik V.L., Amiraslanov E.Y., Leonova A.A., Soldatova E.E.
|
No 9 (2023) |
Clinical and anamnestic features of diseases of the cervix |
|
Levakov S.A., Sheshukova N.A., Obukhova E.A., Dzhafarova M.M., Kaviladze M.G.
|
No 10 (2024) |
Clinical and anamnestic risk factors and prediction models for the development of fetal growth restriction |
|
Gasymova S.R., Tyutyunnik V.L., Kan N.E., Volochaeva M.V., Donnikov A.E.
|
No 11 (2024) |
Clinical and biological efficacy of microfluidic chips for sperm selection in infertility treatment using assisted reproductive technologies |
|
Makarova N.P., Sysoeva A.P., Chernyshev V.S., Lobanova N.N., Kulakova E.V., Kalinina E.A.
|
No 8 (2023) |
Clinical and diagnostic features of uterine subinvolution and postpartum endometritis |
|
Galkina D.E., Makarenko T.A., Fadeeva T.A., Dresvyanskaya T.V.
|
No 3 (2024) |
Clinical and immunological characteristics of women in labor with COVID-19 and their newborn babies |
|
Inviyaeva E.V., Tysyachnyi O.V., Kosolapova Y.A., Vtorushina V.V., Baev O.R., Zubkov V.V., Krechetova L.V.
|
No 2 (2024) |
Clinical and laboratory characteristics of patients with embryonic arrest in the early embryonic period of in vitro fertilization programs |
|
Pogosyan M.T., Nazarenko T.A., Gaysin E.A.
|
No 1 (2025) |
Clinical and medical history characteristics of pregnant women with different cervical cytology results |
|
Rosyuk E.A., Oboskalova T.A., Zornikov D.L., Ten A.R., Askerova M.G., Sevostyanova O.Y., Soloviev D.V., Kudimov A.A., Bikbulatova E.R., Averchenkova E.A.
|
No 4 (2023) |
Clinical and molecular aspects of autologous embryo-cumulus cells co-culture in ifv programs |
|
Asfarova G.R., Smolnikova V.Y., Makarova N.P., Bobrov M.Y., Eldarov C.M., Zingerenko B.V., Kalinina E.A.
|
No 9 (2023) |
Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation |
|
Tezikov Y.V., Lipatov I.S., Zumorina E.M., Azamatov A.R., Tyutyunnik V.L., Kan N.E., Chekalovets A.L., Borisova A.I., Golodnova A.M.
|
No 6 (2024) |
Clinical case of hemorrhagic stroke in a pregnant woman |
|
Ziganshin A.M., Tagirov M.R., Dikke G.B.
|
No 8 (2023) |
Clinical characteristics and analysis of changes in amino acid and organic acid profiles in the urine of patients at risk of preeclampsia |
|
Оshkhunova M.S., Chagovets V.V., Novoselova A.V., Muminova K.T., Gorina K.A., Khodzhaeva Z.S., Frankevich V.E.
|
No 12 (2024) |
Clinical characteristics of dysmenorrhea and its association with lifestyle factors in adolescent girls |
|
Kriuchkova O.M., Istomina N.G., Baranov A.N.
|
No 12 (2023) |
Clinical manifestations and recurrence rates of various forms of extragenital endometriosis |
|
Pronina V.A., Sokolova A.V., Chernukha G.E.
|
No 1 (2025) |
Clinical observation of a patient with eclampsia |
|
Kurtser M.A., Spiridonova E.I., Khvatova A.V., Konoplev B.A., Bagdasaryan P.M., Kambiev R.L., Markov D.V., Kutakova Y.Y., Semenova T.Y., Petrulevich R.A., Medvedskaya A.K.
|
No 8 (2024) |
Clinical risk factors for infertility in reproductive-age patients with intramural uterine fibroids |
|
Dubinskaya E.D., Kolesnikova S.N., Alyoshkina E.V., Gasparov A.S.
|
No 12 (2024) |
Clinical use of expanded genetic testing in the management of couples with unexplained infertility |
|
Martirosyan Y.O., Kadaeva A.I., Bolshakova A.S., Nazarenko T.A., Biryukova A.M., Askeralieva A.N.
|
No 4 (2024) |
Combined hormonal contraceptive containing estetrol and drospirenone: pharmacokinetics and opportunities forclinical use |
|
Nazarova N.M., Prilepskaya V.N.
|
No 8 (2023) |
Communication technologies in promoting the health of pregnant women and children |
|
Dmitrieva E.V., Baibarina E.N., Posiseeva L.V., Ryumina I.I.
|
No 4 (2024) |
Comparative analysis of blood and follicular fluid lipid profiles in women undergoing infertility treatment withassisted reproductive technologies |
|
Fortygina Y.A., Makarova N.P., Drapkina Y.S., Novoselova A.V., Gamisonia A.M., Chagovets V.V., Frankevich V.E., Kalinina E.A.
|
No 2 (2023) |
Comparative analysis of estrogen metabolites when using different forms of estrogen-containing medications in a cryo-protocol for preparation with gonadotropin-releasing hormone agonists |
|
Kvashnina E.V., Tutakov M.A., Tomina E.V., Shilova N.V.
|
No 10 (2024) |
Comparative analysis of pregnancy outcomes after embryo transfer in a stimulated in vitro fertilisation cycle depending on the progestogen type used for post-transfer support |
|
Khramtsova A.Y., Bashmakova N.V., Semenov Y.A., Karibaeva S.K., Melkozerova O.A.
|
No 1 (2023) |
Comparative analysis of the effect of two antihypertensive therapy regimens on maternal hemodynamic parameters in earlyand late-onset preeclampsia |
|
Muminova K.T., Khodzhaeva Z.S., Gorina K.A., Shmakov R.G., Ziganshina M.M.
|
1 - 100 of 584 Items |
1 2 3 4 5 6 > >> |